ABSTRACT
Objective The objective of this investigation is to evaluate binary prediction methods for predicting disease status using high-dimensional genomic data. The central hypothesis is that the Bayesian network (BN)-based method called efficient Bayesian multivariate classifier (EBMC) will do well at this task because EBMC builds on BN-based methods that have performed well at learning epistatic interactions. Method We evaluate how well eight methods perform binary prediction using high-dimensional discrete genomic datasets containing epistatic interactions. The methods are as follows: naive Bayes (NB), model averaging NB (MANB), feature selection NB (FSNB), EBMC, logistic regression (LR), support vector machines (SVM), Lasso, and extreme learning machines (ELM). We use a hundred 1000-single nucleotide polymorphism (SNP) simulated datasets, ten 10 000-SNP datasets, six semi-synthetic sets, and two real genome-wide association studies (GWAS) datasets in our evaluation. Results In fivefold cross-validation studies, the SVM performed best on the 1000-SNP dataset, while the BN-based methods performed best on the other datasets, with EBMC exhibiting the best overall performance. In-sample testing indicates that LR, SVM, Lasso, ELM, and NB tend to overfit the data. Discussion EBMC performed better than NB when there are several strong predictors, whereas NB performed better when there are many weak predictors. Furthermore, for all BN-based methods, prediction capability did not degrade as the dimension increased. Conclusions Our results support the hypothesis that EBMC performs well at binary outcome prediction using high-dimensional discrete datasets containing epistaticlike interactions. Future research using more GWAS datasets is needed to further investigate the potential of EBMC.
BACKGROUND
The advances in high-throughput technologies have provided us with abundant data resources. For example, we have accumulated a huge number of single nucleotide polymorphism (SNP) datasets as a result of genome-wide association studies (GWAS). An SNP results when a nucleotide that is typically present at a specific location on the genomic sequence is replaced by another nucleotide. 1 These high-dimensional GWAS datasets can list over a million SNPs, and whole genome sequencing can produce datasets with hundreds of millions of SNPs. 2 By looking at single-locus associations using these datasets, researchers have identified over 150 risk loci associated with 60 common diseases and traits. [3] [4] [5] [6] However, it is likely that the discovery of loci with significant main effects reveals only a small fraction of the undiscovered genetic risk of many common diseases. [7] [8] [9] [10] [11] That is, much of the genetic risk might be due to undiscovered epistatic interactions, which are interactions by which several genes combined affect disease, and the net effect on phenotype cannot be predicted by simply combining the effects of the individual loci.
In light of its importance, researchers have sought to detect epistasis using genomic data. As standard techniques such as linear regression may not work well because the interactions are nonlinear, other techniques were explored. One wellknown technique is multifactor dimensionality reduction (MDR). 12 MDR combines two or more variables into a single variable and has been successfully applied to detect epistatic interactions in hypertension, 13 sporadic breast cancer, 14 and type II diabetes. 15 Jiang et al 16 evaluated the performance of 22 Bayesian network (BN) scoring criteria and MDR when scoring candidate interactions. They found that several of the BN scoring criteria performed substantially better than other scores and MDR.
A second difficulty when learning epistasis from high-dimensional datasets concerns the curse of dimensionality. That is, there are too many SNPs to look at all possible interactions. Therefore, researchers worked on developing heuristic search methods. Traditional techniques such as logistic regression (LR), 17 LR with an interaction term, 18 penalized LR, 19 and Lasso 20 21 were applied to the task. Other techniques included full interaction modeling, 22 using information gain, 23 24 SNP Harvester, 25 permutation testing, 26 27 the use of ReliefF, 28 29 random forests, 30 predictive rule inference, 31 a variational Bayes algorithm, 32 Bayesian epistasis association mapping, 33 34 maximum entropy conditional probability modeling, 35 a Markov blanket method, 36 an ensemble-based method that uses boosting, 37 and greedy search using BN scoring criteria. 38 Our goal is not only to discover interactions from high-dimensional datasets, but also to use the knowledge learned to perform classification and prediction in a clinical setting. Many binary prediction methods are available, but currently researchers have little reason for choosing one over the other. Just as standard techniques may not work well for learning epistatic interactions from high-dimensional genomic datasets, standard prediction methods may not do well at prediction using these datasets. Several BN-based prediction algorithms have been developed. The most basic is the naive Bayes (NB) classifier. 39 Variations of it that were designed to handle highdimensional data include model averaging NB (MANB), 40 41 feature selection NB (FSNB), 40 and the efficient Bayesian multivariate classifier (EBMC). 42 In an effort at consolidating these efforts and determining which methods work well for this problem, we compare the prediction performance of the BN-based methods to LR, support vector machines (SVM), 43 Lasso, 20 and extreme learning machines (ELM). 44 
OBJECTIVE
The objective of this investigation is to evaluate the performance of binary prediction methods when predicting disease status using high-dimensional discrete genomic data. Our central hypothesis is that the BN-based method EBMC will do well at this task because EBMC builds on BN-based methods that have performed well at learning epistatic interactions.
METHOD
We first review the methods we applied.
Bayesian networks
BNs 39 45-48 are used for uncertain reasoning and machine learning in many domains, including biomedical informatics. [49] [50] [51] [52] [53] [54] A BN consists of a directed acyclic graph (DAG) G ¼ ðV; EÞ, whose nodeset V contains random variables and whose edges E represent relationships among the random variables. A BN also includes a conditional probability distribution of each node X [ V given each combination of values of its parents. Each node V in a BN is conditionally independent of all its nondescendents given its parents in the BN. Figure 1 shows a causal BN modeling the situation that SNP rs7115850 and the APOE gene both have a causal inference on late onset Alzheimer's disease (LOAD) and LOAD has a causal influence on mental dexterity.
Using a BN, we can determine conditional probabilities of interest with a BN inference algorithm. 45 The problem of doing inference in BNs is NP-hard. 55 The task of learning a BN from data concerns learning both the parameters in a BN and the structure (called a DAG model). In a score-based structure learning approach, we assign a score to a DAG based on how well the DAG fits the data. Cooper and Herskovits 56 introduced the Bayesian score, which is the probability of the Data given the model G. A popular variation of the Bayesian score is the Bayesian Dirichlet equivalent uniform (BDeu) score, 57 which allows the user to specify priors for the conditional probability distributions using a single hyperparameter a, called the prior equivalent sample size. That score is as follows:
where r i is the number of states of node X i , q i is the number of different instantiations of the parents of X i , and s ijk is the number of times in the data that X i took its kth value when the parents of X i had their jth instantiation. Finding the DAG model that maximizes a Bayesian score is NP-hard. 58 
Bayesian networks classifiers
We present four different but related BN classifiers.
Naive Bayesian networks
Ideally, we would like to identify all the SNPs that predict a clinical disease outcome of interest, and have those SNPs be parents of the disease outcome in a BN. However, unless there are only a few predictors, we usually do not have sufficient data to learn such a network. For example, if all variables are binary and we have only 10 predictors, there are 1024 combinations of values of the predictors. An approach often taken to circumvent this dilemma is to make the predictors children of the outcome. Such a network is called an NB network, and when used for classification it is called an NB classifier. 39 Figure 2 shows the DAG model for an NB classifier when six SNPs are being used to predict disease D.
Suppose we have Data concerning the status of disease D and values of the six SNP predictors of D. To develop an NB classifier from these Data we learn the conditional probability distribution of each SNP S i given D from the Data, and ascertain the prior probability of D in the population in which the classifier will be used. These probability distributions, along with the Figure 1 A Bayesian network modeling the situation that single nucleotide polymorphism (SNP) rs7115850 and the APOE gene cause late onset Alzheimer's disease (LOAD), and mental dexterity. SNPs have two alleles A and B; so the value of an SNP in a human being can be AA, AB, or BB, which we label 0, 1, and 2. The APOE gene has four alleles: E1, E2, E3, and E4. We have modeled three levels of mental dexterity. figure 2, fully specify a BN PðS i jDÞPðDÞ;
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where K is a normalizing constant. The last equality above is because the SNPs are being modeled as independent of each other upon conditioning on their parent D. A naive BN classifier is a probabilistic classifier in that it provides the probability of disease status given Data.
Feature selection naive Bayes
When we have many possible SNP predictors, we do not know which of them are predictors of disease status. One alternative is to try to learn the predictors from the Data, and then use those predictors in an NB classifier. FSNB 40 uses this strategy. That is, it learns the predictors for a unique NB classifier, and then uses that unique classifier to perform inference. It learns the DAG model by starting with the model containing no SNPs. It then uses a greedy forward search that adds the SNP to the model that most increases the Bayesian score (equation 1) of the model. When no additional features increase the score, the search stops.
Model averaging naive Bayes
Another alternative is to consider all possible subsets of the set of all SNPs as possible predictors of the disease, compute the probability of the disease using an NB classifier containing each of the subsets, and then average over all the classifiers. Formally, we use the law of total probability as follows:
where the sum is over all naive BN classifier models M containing subsets of the SNPs. This strategy is called MANB. 40 41 Since there are 2 n subsets of n SNPs, it is not possible to compute the sum in equation 2 by brute force. By exploiting the conditional independencies, it is possible to compute equation 2 in time that is linear in n.
Efficient Bayesian multivariate classifier
A problem with an NB network is that it makes strong conditional independence assumptions. That is, it assumes that the predictors are conditionally independent given the outcome, whereas often they are conditionally dependent given the outcome. The EBMC 42 ameliorates this difficulty. EBMC searches for predictors similar to FSNB, but does so in a more refined manner.
We describe the search algorithm in EBMC using an example that is adapted from Cooper et al. 42 As illustrated in figure 3 , the algorithm starts by scoring all DAG models in which a single SNP is the parent of disease node D, using the BDeu score (equation 1). The model containing the highest scoring SNP is our initial model as shown in figure 3A , where we have labeled the SNP as S 1 . We then determine which SNP when added as a parent of D to this 1-SNP model yields the highest scoring 2-SNP model. If that 2-SNP model has a higher score than our 1-SNP model, our new model becomes that 2-SNP model as depicted in figure 3B . We greedily keep adding SNPs to the model as long as we can increase the score. When no SNP increases the score further, we search for an SNP such that deleting the SNP increases the score, and we delete the SNP whose deletion increases the score the most. We keep deleting SNPs until no deletion increases the score. Suppose our final model is the one in figure 3B . We then make the SNPs in the model children of D and create edges between them. The result is the model in figure 3C . This is the result we would obtain given the causal relationships in figure 1 if the loci we learned were SNP rs7115850 and the APOE gene. Next the search continues in the same manner, identifying additional SNPs that are parents of D. That is, we first identify the single SNP that when added as a parent of D to the model in figure 3C increases the score of that model the most. We again proceed with a greedy forward and backward search. Suppose the search yields two additional SNPs. We then have the model in figure 3D . In the same way as before, we make the new SNPs children of D and create edges between them. The result appears in figure 3E . The search repeatedly continues in this manner until we cannot increase the score further. The network produced by EBMC is called an augmented NB network. 59 An algorithm for EBMC appears in the online supplementary material.
Other methods tested
We compared the BN-based methods to LR, which is a standard probabilistic binary classifier, the SVM, 43 which is a nonprobabilistic machine learning binary classifier, Lasso, 20 which is regression-based and does shrinkage that allows a variable to be partly included in the model, and the neural network-based non-probabilistic binary classifier ELM. 43 
Evaluation methodology
We evaluated NB, MANB, FSNB, EBMC, LR, SVM, Lasso, and ELM using 110 simulated datasets, six semi-synthetic sets, and two real GWAS datasets. We used our own implementations of NB, MANB, FSNB, and EBMC, and the publicly available implementions of SVM at LIBLINEAR 60 and LIBSVM, 61 Lasso at lasso4j, 62 and ELM at ELM. 63 Our implementations are not yet publicly available. The SVM packages we used provides a linear kernel in LIBLINEAR and the radial basis function (RBF) kernel in LIBSVM. Overfitting occurs when a model describes the data well, but as a result describes the underlying relationships poorly. A model tries to avoid overfitting by employing regularization. The linear kernel uses a penalty parameter C to handle regularization. We used the following values of C in our studies: 2 −5 , 2 −1 , 2 3 , 2 7 , 2 11 , and 2 15 . The RBF kernel uses both the parameter C and a kernel parameter γ. We used the same values of C as those used for the linear kernel, and the following values of γ: −15, −11, −7, −3, 1, 5. We combined every value of C with every value of γ. In ELM we can specify the number of hidden nodes. We ran ELM with 10, 500, and 1000 hidden nodes. In the BN-based methods, we used the BDeu score with α=9. All experiments were run using a Dell PowerEdge R515 server which has an AMD Opteron 4276HE, 2.6 GHz, 8C, Turbo CORE, 8M L2/8M L3, 1600 MHz Max Mem single processor and an additional AMD Opteron 4276HE, 2.6 GHz, 8C, Turbo CORE, 8M L2/8M L3, 1600 MHz Max Mem processor.
Simulated datasets
Chen et al 64 generated datasets based on two 2-SNP epistatic interactions, two 3-SNP epistatic interactions, and one 5-SNP epistatic interaction, making a total of 15 predictive SNPs. Each dataset contains 1000 cases and 1000 controls. Three parameters were varied to create the interactions: (1) u, which determined the penetrance; (2) b, which determined the minor allele frequency; and (3) l, which determined the linkage disequilibrium of the true causative SNPs with the observed SNPs. The effects of the interactions were combined using a Noisy-OR model. 45 In our evaluation, we used the hundred 1000-SNP datasets and the ten 10 000-SNP datasets developed by Chen et al, with b ¼ 1, b ¼ 1, and l ¼ null.
Real and semi-synthetic datasets
Reiman et al 65 developed a LOAD GWAS dataset that contained data on 312 260 SNPs and had records on 861 cases and 644 controls. We used this real GWAS dataset in our evaluation. Hunter et al 66 conducted a GWAS on 546 646 SNPs and breast cancer. The dataset consists of 1145 cases and 1142 controls. In addition to using this real GWAS dataset directly in our evaluation, we also used it to create semi-synthetic datasets. To create one of these datasets, we generated data on 15 predictive SNPs in the same way as described above for the simulated datasets. We then injected these data into the real breast cancer GWAS dataset, resulting in a semi-synthetic dataset. We developed six such semi-synthetic datasets.
RESULTS

Simulated datasets
In k-fold cross-validation, we divide the data into k partitions of the same size. For each partition j, we train using the data in the remaining k − 1 partitions to yield a model, and we compute the error for each data item in partition j when applying this model. We evaluated the methods using fivefold crossvalidation. In order to judge to what extent a method overfit the data, we also carried out in-sample testing in which we used the entire dataset to learn the model, and then used the learned model to do prediction for the entire dataset. Figure 4 plots the average AUROCs for the methods. In the fivefold cross-validation, LIBSVM performed the best on the 1000-SNP datasets, but its performance degraded on the 10 000-SNP datasets. EBMC performed best on the 10 000-SNP datasets, exhibiting the same performance as on the 1000-SNP datasets. Other than NB, the BN-based methods did not do much better in the in-sample testing than in the fivefold cross-validation, indicating that they do not tend to overfit the data. On the other hand, NB and the non-Bayesian methods performed better in the in-sample testing, indicate that these methods tend to overfit the data. As can be seen in online supplementary table S2, LIBSVM is substantially slower than the other methods. On average it took EBMC, LIBLINEAR best, and LIBSVM best 2.2 m, 4.77 s, and 0.44 h, respectively, to handle one 10 000-SNP dataset.
LIBSVM is a non-probabilistic classifier. For such classifiers it is worthwhile to investigate the actual true positive and false positive rates. LIBSVM achieved its average AUROC of 0.760 on the 1000-SNP datasets with an average true positive rate of 0.548 and an average false positive rate of 0.027. In applications where it is more important to avoid false positives, this performance would be good. On the other hand, if true positives are more important and some false positives can be tolerated, this would not be good performance. 
Real and semi-synthetic datasets
We again evaluated the systems using fivefold cross-validation and in-sample testing. Lasso was not included in the evaluation because it could not handle so many SNPs. LIBSVM was also not included owing to memory problems; we could not get LIBSVM to run even when 60 GBs were allocated. Table 2 shows the AUROCs for the fivefold cross-validation when the methods analyze the real LOAD and breast cancer datasets, and the average AUROC when they analyze the semi-synthetic datasets . Online supplementary table S3 shows the in-sample testing  results, while online supplementary table S4 shows the running times. Figure 5 plots the AUROCs for the methods when analyzing the LOAD dataset. The fivefold cross-validation results for the LOAD dataset were similar to those for the simulated datasets. We investigated EBMC further when analyzing the LOAD dataset. Figure 6 shows the BN model learned by EBMC from the entire LOAD dataset. APOE is the strongest genetic risk factor for LOAD. 65 SNP rs7115850 is on the GAB2 gene, and previous research has indicated the APOE and GAB2 genes interact to affect LOAD. 65 The edge from SNP rs7115850 to APOE captures this interaction. SNP rs6784615 is on the NISCH gene; recent research has associated this gene by itself with LOAD. 67 Note that EBMC did not place an edge between this SNP and either of the other predictors. So these associations in the EBMC model are consistent with studies in the literature. The models obtained in the fivefold cross-validation studies were not as consistent with known biological information as the model in figure  6 . They all contained the APOE gene, but none found the GAB2 gene. Model 1 contained the NISCH gene and APOE, model 3 contained only APOE, model 4 contained SNP rs7335085 and APOE, and model 5 contained SNP rs58766952 and APOE. We know of no previous research linking these latter two SNPs to LOAD. The fact that we learn from less data in the cross-validation studies may account for the inferior discovery. On the other hand, the fact that APOE is such a strong signal likely accounts for the fact that the performance is still good in these studies.
The fivefold cross-validation breast cancer results are interesting and surprising. Most of the methods found no signal at all. However, LIBLINEAR found a very weak signal, and NB found a stronger but still weak signal. We obtained 95% CIs for the AUROCs of LIBLINEAR best and NB equal to (0.500 to 0.548) and (0.505 to 0.553), respectively, so we can be reasonably confident that this is a faint signal and not noise. When analyzing this dataset using the Bayesian network posterior probability (BNPP) method, Jiang et al 68 found that no SNP had a posterior probability great than 0.01, but there were many SNPs with posterior probabilities close to 0.003. This indicates that there is no strong predictor in this dataset, but many possible weak ones. (Note that BRCA1 and BRCA2 are not included in this dataset because they are too rare to qualify. Furthermore, the study is in postmenopausal women, and these genes are known to be risk factors in premenopausal women.) So, many SNPs could be interacting to provide this weak signal. Such a result is consistent with the fact that studies have shown that thousands of genes may be associated with breast cancer. 69 Furthermore, when we inject the five interactions into the breast cancer dataset, NB does better than the other methods and also better than any of the results for the simulated datasets. NB does Figure 4 Average area under the receiver operating characteristic curves (AUROCs) for the methods when the 1000-single nucleotide polymorphism (SNP) and 10 000-SNP datasets are analyzed. EBMC, efficient Bayesian multivariate classifier; ELM, extreme learning machines; FSNB, feature selection naive Bayes; LR, logistic regression; MANB, model averaging naive Bayes; NB, naive Bayes; SNP, single nucleotide polymorphism. prediction using all possible predictors. It seems that this strategy may work well in this situation because it combines the predictive value of the injected SNPs with the weak signal of the multitude of real predictors to achieve its predictive capability. Further analysis with additional real and real/combined datasets is needed to investigate this conjecture.
DISCUSSION
LIBSVM performed best on the 1000-SNP datasets. EBMC performed best on the 10 000-SNP datasets and slightly behind MANB on the LOAD dataset. In the studies on the breast cancer dataset, NB performed best. EBMC searches for good predictors and then uses them to carry out prediction, whereas NB simply uses all possible predictors. Our results indicate that the former approach might work better when there are several strong predictors, whereas the latter approach might work better when there are many weak predictors.
Using the same simulated datasets as those used in our analysis, Chen et al 64 compared the performance of eight methods for discovering epistatic interactions. All methods performed substantially worse on the 10 000-SNP datasets than on the 1000-SNP datasets. Since the 10 000-SNP datasets contain more non-predictors, it is more difficult to find the 15 actual predictors when analyzing these datasets. However, our prediction results using EBMC obtained AUROCs of around 0.70 for the 1000-SNP datasets, the 10 000-SNP datasets, and the semisynthetic breast cancer datasets containing 546 646 SNPs. This result indicates that EBMC's predictive ability hardly degrades as we increase the number of SNPs, even if the discovery performance does degrade.
In future research, we can generate more simulated datasets with different numbers of interacting SNPs and different values of u, b, and l. We can then further investigate the performance of LIBSVM, EBMC, and NB using various values of their tuning parameters. We can identify which method performs best in each situation.
We evaluated our methods using a real LOAD GWAS dataset which has a strong SNP signal, and a real breast cancer GWAS dataset which has a weak SNP signal. Future research can further investigate their performance using a real GWAS dataset in a domain believed to have a moderate SNP signal such as rheumatoid arthritis. 70 
CONCLUSIONS
Our investigations support the hypothesis that EBMC performs binary prediction using high-dimensional genomic datasets well. It exhibited the best overall performance of eight methods tested, although LIBSVM, MANB, and NB performed better in certain cases.
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